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Immune repertoires rely on diversity of T-cell and B-cell receptors to protect us against foreign
threats. The ability to recognize a wide variety of pathogens is linked to the number of different
clonotypes expressed by an individual. Out of the estimated ∼ 1012 different B and T cells in
humans, how many of them express distinct receptors? We review current and past estimates for
these numbers. We point out a fundamental limitation of current methods, which ignore the tail of
small clones in the distribution of clone sizes. We show that this tail strongly affects the total number
of clones, but it is impractical to access experimentally. We propose that combining statistical models
with mechanistic models of lymphocyte clonal dynamics offers possible new strategies for estimating
the number of clones.
I. INTRODUCTION
The diversity of immune repertoires plays an impor-
tant role in the host’s ability to recognize and control
a wide range of pathogens. While actual recognition of
an antigen depends on having a relatively specific T-cell
or B-cell receptor (TCR or BCR), multiple experimen-
tal examples show that reduced receptor diversity may
limit the efficacy of adaptive immune repertoires [1, 2].
This effect becomes especially pronounced in individuals
infected with cytomegalovirus [3–5], or with immunose-
nescence [6], when naive clonotypes are significantly re-
duced, and the organism is left to rely on reduced immune
diversity.
The number of different clonotypes, called species rich-
ness in ecology, is thus an important quantity to esti-
mate, both biologically and clinically. Here we review
some of the experimental and theoretical approaches that
have been used to estimate the number of distinct clono-
types in TCR and BCR repertoires, in naive, memory, or
unfractionned repertoires. Based on existing repertoire
data and computational models, we demonstrate that no
statistical method can overcome the limitations of small
sampling. We argue that this problem, which is inherent
to all existing methods, could be overcome by combin-
ing repertoire data with stochastic models of lymphocyte
population dynamics, taking into account the caveats of
convergent recombination and experimental noise.
II. PAST ESTIMATES
The variable part of each TCR β (and BCR heavy)
chain is composed by putting together variable (V), di-
verse (D) and joining (J) regions. TCR α (and BCR
light) chains only have V and J genes and no D genes.
Additionally each chain experiences additions and dele-
tions of nucleotides at the gene junctions, which increases
the diversity. This junctional rearrangements have been
identified as the main contributor to sequence diver-
sity [7, 8]. The α and β chain generations in TCR are
separated in time, and have been shown to be indepen-
dent [9, 10]. The total number of different αβ pairs that
the generation machinery can produce is much greater
than the total number of receptors in the whole human
population [9, 11, 12]. Thus, each person harbors only
a small fraction of the potential diversity of receptors.
To estimate the number of distinct receptors, we need to
count them.
An early quantitative direct estimate of the size of the
TCR repertoire dates back to Arstila et al [13], follow-
ing earlier considerations [7, 14]. Their approach was to
focus on a subclass of receptors (either α or β) with a
specific V-J class and length, and sequence them using
low-throughput methods. The number of different se-
quences in that subclass is then extrapolated back to the
get the full diversity by dividing by the known frequency
of V-J and length usage. The authors were very care-
ful to verify their estimate in different V-J classes and
donors, and to account for rare clonotypes that might
have escaped sequencing. A total of ∼ 106 different TCR
β chains were thus estimated in a sample of 108 T-cells.
Each β chain paired with 25 different α chains, resulting
in ∼ 25 · 106 distinct TCRαβ. Much smaller TCR αβ
diversity was reported in the memory subset, ∼ 2 · 105,
consistent with the idea that memory cells form a selected
and thus restricted subset.
With the onset of high-throughput sequencing of im-
mune receptor repertoires [15–23] came the realization of
the importance of the sampling problem. In sequenced
repertoires, many clonotypes are seen just once, suggest-
ing that there are possibly many more that have similar
or slightly smaller sizes but were not sequenced, simply
by chance. This issue does not only affect “small” clones.
A clone of 105 cells among a total of 3 · 1011 T cells will
often not be seen even once in a typical sample of 106
cells. To deal with this issue, a commonly adopted ap-
proach has been to use statistical estimators (see [24] for
a overview).
Using the Poisson abundance statistical method [25],
Robins et al [16] obtained estimates of ∼ 106 TCRβ nu-
cleotide clonotypes for CD8 and CD4 naive cells, and
∼ 5 · 105-106 for CD8 and CD4 memory TCRβ. Qi
et al. [6] used another method called the Chao2 es-
timator [26], which uses multiple replicates of the se-
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2quencing experiment, to estimate TCR species richness.
They obtained much larger estimates than Robins et al.:
∼ 2 · 108 TCRβ nucleotide clonotypes in CD4 and CD8
naive repertoires, ∼ 1.5 · 106 clonotypes in CD4 memory
repertoires, and about 5-10 times fewer in CD8 mem-
ory. All those numbers decreased with age. Using the
Poisson abundance method, diversities of ∼ 1-2 · 109 for
naive and ∼ 5 · 107-108 for memory BCR heavy chains
were reported [27]. Recent estimates of BCR heavy-chain
species richness using an advanced statistical estimator
[28] yielded smaller diversities, ranging from ∼ 107 [29] to
107-109 [30], presumably because they focused on amino
acid rather than nucleotide clonotypes and ignored hy-
permutations in the V and J segments.
III. THE SAMPLING PROBLEM
The approaches described above share the common
problem that it is impossible to extrapolate what hap-
pens for small clones from small samples, which capture
the largest clones [24, 28]. Getting information on the
small clonse is in fact impractical: it would require se-
quencing essentially all lymphocytes in an organism. Hu-
mans harbor of the order of 3 · 1011 T cells (and roughly
the same order of B cells). Of these, only a few percents
are contained in blood, of which a small fraction (∼ 106)
is sampled in typical experiments (Fig. 1A). Even in mice,
which contain fewer lymphocytes (∼ 108 T cells) and can
be sacrificed to isolate all the body’s lymphocytes, cell
loss during the experiment hampers this approach.
In Fig. 1B-D, we illustrate with simulations what hap-
pens when one analyses samples of 106 cells from three
synthetic repertoires. These repertoires are described
by different clone size distributions, corresponding to
a widely different number of clones: a pure power law
(Fig. 1B), a mixture of a power law and neutral model
[31] (Fig. 1C), and a power law with a low-frequency cut-
off (Fig. 1D). Their species richness are widely different,
ranging from N ∼ 7 · 105 to 1.6 · 1010. Yet, the sam-
pled repertoires show similar clone size distributions, and
comparable observed diversity (105-106), because they
behave similarly for large clone sizes, but drastically dif-
fer in the tail of small clone sizes.
Any statistical method that extrapolates from obser-
vations assumes, knowingly or implicitly, an underlying
model for how the clone size distribution behaves for the
smallest clones. The Poisson abundance and Chao esti-
mators [25, 26, 32] discussed earlier both assume a well
peaked distribution of clone sizes, which is not the case in
our examples. As a result, the Chao1 [32] estimator can
underestimate species richness by up to a 1,000-fold fac-
tor (Fig. 1B). A more advanced estimator such as Recon
[28] gives even worst underestimates.
Real repertoires are likely affected by this problem.
The sampled (large clone) part of their clone size distri-
bution has been shown to follow a power law both for
TCR and BCR [11]. Naive subsets display shorter tails
of large clones [33], suggesting that the power-law be-
haviour in unfractioned repertoires is dominated by mem-
ory clones. Our three synthetic examples are consistent
with power laws for large clones, but differ greatly for
small clones, yielding very different species richness. Ex-
trapolating the distribution of clone sizes is the key idea
behind DivE [34] and Recon [28], which were proposed
to estimate diversity in TCR subsets. However, these
approaches assume that the behaviour at large clones is
informative for small clones, which may not always be
true.
IV. PROPOSED SOLUTION: STOCHASTIC
MODELING
To access small clones that cannot be directly probed
experimentally, we need to explicitly model the biological
processes that shape these distributions, without hav-
ing to take a leap of faith. Unlike extrapolation, such
models might predict behaviours for small clones that
are quantitatively different than the trend suggested by
large clones. Of course, model assumptions should be
tested experimentally, their parameters estimated from
measurements, and confidence intervals put on their pre-
dictions. We now briefly review two simple models that
have been proposed to describe the dynamics and clone
size distributions of naive and memory repertoires.
Cells in naive repertoires have not experienced strong
proliferation due to antigen recognition. Nevertheless not
all clones are of the same size, in part because clones
leave the thymus with different initial sizes, and in part
because they undergo stochastic division and death. The
simplest model of naive repertoires is Hubbell’s neutral
model of ecology [31], which assumes constant division
and death rates (ν < µ) for each cell, with new clones in-
troduced with rate θ and constant initial size k (Fig. 2A,
left). More complex variants of that model may include
intrinsic fitness differences between clones or cells, e.g.
through competition for self-antigens [35] or cytokines
[36].
Under that simple model, the steady state distribution
of clones can be computed analytically [36–38], and falls
off exponentially for clones larger than k (Fig. 2A, right),
meaning that large clones are rare. The total number of
clones N can also be calculated analytically as a function
of the model parameters µ, ν, and k, as well as the total
number of cells T (Fig 2C). Unless cell division almost
exactly balances death (ν ∼ µ), or the introduction clone
size k is large, the typical naive clone size is fairly small.
This means that the total number of clones is very large,
and comparable to the total number of cells. To get
a more precise estimate would require to measure the
division rate of naive T cells ν, and initial clone size k.
A limitation of this approach is the assumption that
the clone size distribution quickly reaches a steady state.
Naive T cells are very long-lived µ−1 ∼ 3 years [39], and
the size of the naive pool changes with age, so that steady
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FIG. 1. Estimating the total number of B or T cell clonotypes from small samples is generally impossible. A.
Orders of magnitude for the number of T cells. Only one or a few percent of all T =∼ 3 · 1011 T cells circulate in blood at any
given time. Among these, typical sequenced samples contain about a million cells, which is a tiny fraction of the total repertoire.
The number of T cells in a mouse is shown for comparison. Similar numbers hold for B cells. B.-D. Rank-frequency plots of
three synthetic repertoires showing the frequency of B- or T-cell clones versus their rank (from most frequent to least frequent).
The corresponding clone size distribution is shown in the inset: B) power-law distribution; C) mixture of power-distribution
and neutral distribution (see main text); D) power-law distribution with low-frequency cutoff. A random of sample of 106
cells (in red) fails to capture most of the true rank-frequency relation (in blue). While the sampled distribution looks similar
in all three cases, the true distributions are very different in the domain of low clonal frequencies, and correspond to a widely
different number of clones Ntrue. That number is very poorly estimated by the number of sampled clones (Nsample), or by
statistical estimators such as Chao1 (NChao) [32], or Recon (Nrecon) [28].
state may never be reached. Transient models of naive
repertoires remain to be explored in more detail. A recent
experimental study suggests that some T-cell naive clones
are much larger than predicted by the neutral theory
[37]. However the origin of these outliers is not yet well
understood, and may have to do with the inadequacy of
our current definitions of naive and memory cells through
surface markers.
Modeling memory repertoires requires taking into ac-
count the expansion and then contraction dynamics af-
ter an infection. These dynamics are driven by new
pathogens that infect the host, are recognized and then
cleared [40], which leads to a constantly changing anti-
genic landscape [36]. This random encounter with anti-
gens can be simply modeled by bursts of division events
for all cells of the same clone, with rate r, causing each
cell to effectively multiply m times into memory following
antigen clearance (Fig. 2B, left). Again, this model can
be solved exactly in the continuous limit at steady state.
The clone size distribution follows a power law for large
clones (Fig. 2B, right). The predicted number of clones
N depends critically on the power law exponent α, and
can be calculated as a function of the model parameters
(Fig. 2D). N drops to zero for power law exponent α
close to 1. Interestingly, measured exponents α from un-
fractioned T cell β chain repertoires (whose large-clone
tail is believed to be dominated by memory clones) range
from 1 to ∼ 1.5 [11]. This high sensitivity to parameters
makes estimates from data very difficult.
Extensions of this model include the emergence of anti-
genic “niches” [41], where clonal expansion is limited by
antigen availability, leading to diminishing returns upon
multiple stimulation events [42]. Such mechanisms would
limit the size of the largest clones and would cut off the
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FIG. 2. Lymphocyte population dynamics models can be used to estimate the number of clones. A. Neutral
model for lymphocyte dynamics. New clones come out of the thymus (for T cells) or bone marrow (for B cells) with rate θ,
with initial clone size k. Then each cell may divide with rate ν, and die with rate µ > ν. The clone size distribution at steady
state can be calculate and falls off rapidly (right). B. A minimal clonal selection model. Instead of dividing randomly, cells of
the same clone all proliferate m-fold upon immune stimulation, which occurs with rate r. The clone size distribution of this
process behaves as a power law for large clones. The exponent of the power law can be expressed as a function of the model
parameters. C.-D. The total number of clones can be expressed as a function of the model parameters for C) the neutral
model D) the clonal selection model, and the total number of cells in the body, T = 3 · 1011. In the neutral model, the typical
size of clones increases and diverges when division and death balance each other, µ ∼ ν, leading to reduced diversity for a fixed
number of cells. In the selection model, a similar divergence is observed as the power law exponent α gets close to 1.
power law behaviour, which is not observed in data.
V. CONNECTING MODELS TO DATA
Several caveats and corrections must be taken into ac-
count when linking stochastic models of population dy-
namics such as discussed above to repertoire data. Of
importances are the issues of convergent recombination
and experimental noise.
Population dynamics models focus on clones, defined
as the set of cells originating from a common recombi-
nation event. However, two recombination events can
lead to exactly the same sequence. The two correspond-
ing clones would be indistinguishable, and form a single
clonotype in the repertoire. This effect can be corrected
for by using models of recombination [43, 44]. These
models, which are inferred from data, can predict the
distribution of generation probabilities of full receptors,
or of single chains, both at the level of nucletoide or
amino acid sequences, as shown in Fig. 3A for TCR. From
this distribution, the probability of convergent recombi-
nation can be computed to predict the number of dis-
tinct clonotypes as a function of the number of “clones”,
defined as independent recombination events (Eq. 7 of
[12]). In Fig. 3B we plot that prediction for the α, β,
and αβ TCR in humans, for both nucleotide and amino
acid clonotypes. These computations show that, for the
full TCRαβ clonotypes, convergent recombination is so
rare that it hardly affects species richness. For the α and
β chains alone, however, the effect is substantial. Since
most repertoire data are of single chains, this correction
should be applied when linking data to the type of models
discussed above, as was done in Ref. [37].
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FIG. 3. Convergent recombination. A. Distributions of generation probabilities for the α and β chains as well as αβ pairs of
T-cell receptors, for both nucleotide and amino-acid sequences, calculated using the OLGA software [44]. Most clonotypes have
very low probability and are therefore unlikely to occur in two clones independently. High-probability clonotypes, however,
will be generated several times in distinct T-cell clones (convergent recombination), reducing their diversity. B. Impact of
convergent recombination on clonotype diversity. The ratio of the number of clonotypes to the number of clones is calculated
using a model of recombination using OLGA, with the additional assumption that a random fraction q of recombination events
fail to pass selection [12]. This ratio decreases as the number of clones increases, as redundant recombination events become
more likely. The magnitude of this effect depends on the definition of clonotype (single chains or αβ pairs, amino acids or
nucleotides). It is small for full αβ pairs. Inset: number of distinct clonotypes as a function of the number of clones. Selection
parameter q: qα = 0.046, qβ = 0.0091, and qαβ = qαqβ (taken from Refs. [9, 12]).
An additionnal issue complicates the comparison of
models to data: experimental noise in the observed fre-
quencies of clonotypes. In practice the number of reads
(or unique molecular identifiers when they are used) n
observed in data for a given clonotype is not simply the
result of random sampling, and is not distributed accord-
ing to a Poisson law, as was assumed in Fig. 1 and in all
previous work on diversity estimation. Instead, noise is
over-dispersed, due to additional noise caused by DNA
amplification and library preparation prior to sequenc-
ing. This noise model can be fitted using replicates of
the repertoire sequencing experiment. This inference is
impossible to separate from the inference of the clone size
distribution ρ(f). The two must thus be learned simul-
taneously from replicates by maximizing the likelihood
of observed abundances, which depend on both the clone
size distribution and the noise properties [45]. Applying
this approach to the β chain of unpartioned T cells with
ρ(f) ∝ f−1−α, yields species richness of N ∼ 108 − 109,
with power-law exponent α ≈ 1-1.2 [45]. In this esti-
mate, the power law is taken as a given, and not linked
to a model of clonal dynamics. A full mechanistic model
treatment combined with the statistical model remains
an interesting direction to explore, which could help shed
light on the differences between memory and naive reper-
toires.
VI. SAMPLING AND REPERTOIRE SHARING
Several recent papers have focused on shared immune
receptors from high throughput BCR repertoire data
[29, 30, 46]. These high profile analyses report absolute
percentages of shared clonotypes. However, it was shown
in the context of TCR (but the same holds for BCR)
that these fractions are not absolute properties of the
repertoires, but rather depend on sampling depth and the
number of individuals that share the clonotypes [11, 12].
Sharing estimates based on samples of the repertoire are
bound to grossly underestimate the true sharing fraction.
Therefore, reporting sharing percentages without appro-
priate information about sample sizes is meaningless.
To assess the true overlap between the repertoires of
two or more individuals, we would need to sequence all
their lymphocytes, which is impractical. However, sta-
tistical model of sequence probabilities can be used to
extrapolate sharing estimates to the full repertoire size
N , provided that number is known [12]. For instance,
clonotypes whose probability p is larger than 1/N are
expected to be present in 1− e−pN > 63% of individuals,
and can be considered “public”. Recombination models
such as the one of Fig. 3A can be used to estimate the
fraction of clonotypes that are public. For example, for
N = 1010, the model predicts that about 15% of TCRβ
amino acid clonotypes expressed by human individuals
are public [12].
6VII. CONCLUSIONS
While we have focused our review on the number of dis-
tinct clonotypes, what really matters for biological func-
tion is the number of different specificities. Due to cross-
reactivity, each receptor can recognize many antigens and
each antigen can be recognized by many receptors with
different strengths. To account for this degeneracy, we
would need to define a functional coverage of the anti-
genic space [47]. However, we currently do not have a
comprehensive sequence-to-function maps for TCR and
BCR that would allow us to estimate such a quantity.
Simply counting clonotypes also ignores their relative
abundances. Clonotypes expressed by very few cells may
not be as relevant for immune protection as very frequent
clonotypes. Other diversity measures such as Hill num-
bers account for differences in frequencies [11, 48]. Some
of these measures are in fact more robust than species
richness, because they put more focus on large clones
and are less susceptible to sampling noise. Depending on
the question, these measures may be better suited than
species richness.
Our discussion has focused mostly on T cells, and has
ignored the complications of hypermutations in BCR,
which cause lineages to split into many clonotypes.
Whether diversity is defined at the level of lineages or
clonotypes will lead to different answers [27, 29, 30]. De-
velopping specialized population dynamics models of B
cell development and affinity maturation that include hy-
permutations is an interesting research direction.
We emphasized that estimating species richness can-
not be disentangled from estimating the full distribution
of clone sizes. As we gain insight into various aspects of
lymphocyte dynamics, from thymic output to infection
and memory formation, better mathematical descriptions
can be leveraged to propose refined forms for the clone
size distribution, and to fit their parameters to observa-
tions. Only with such a combination of modeling and
data will we be able to get a better picture of repertoire
diversity and immune coverage.
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